Adage Capital Partners Gp, L.L.C. Spruce Biosciences, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.01 - $11.26 $1.45 Million - $2.71 Million	-240,511 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.12 - $17.46 $505,999 - $873,000	-50,000 Reduced 17.21%	240,511 $2.7 Million
Q4 2020 Feb 16, 2021	BUY	$15.38 - $32.42 $4.47 Million - $9.42 Million	290,511 New	290,511 $7.06 Million

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.